secwatch / observer
WGRX Wellgistics Health, Inc.
CIK 0002030763 50 ready 8-Ks latest June 2, 2026, 4:15 PM ET RSS · JSON
Activity: ELEVATED 9 filings / 30d vs 3 baseline Risk accumulating: auditor change (4)
Ready 8-Ks 50
Latest filing June 2, 2026, 4:15 PM ET
Top materiality 0.85
Event mix other_material ×30 · leadership ×6 · debt ×5
Sentiment 15 pos · 7 neg · 28 neu
Latest earnings reported 2026-Q1
Executive change recent →

Recent material events

  1. Listing & Compliance Notices Wellgistics Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
    “December 9, 2025, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until June 8, 2026 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by June 8, 2026, the Company may be eligible for an additional 180-day period to reg”
    December 16, 2025, 6:59 PM ET · SEC source · SEC 8-K Item 3.01
  2. Material Agreements Wellgistics Health, Inc. entered into Collaboration Agreement with Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC valued at $2,000,000 (effective 2026-04-13).
    “On April 13, 2026, Wellgistics Health, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with Kare Rx Hub, LLC (“Kare Hub”), Kare Pharmtech, LLC (“Kare Pharmtech”), and Healthstar Technologies, LLC (“Healthstar”), pursuant to which the parties agreed to collaborate through a newly formed limited liability company structure.”
    April 17, 2026, 7:59 PM ET · SEC source · SEC 8-K Item 1.01/1.02
  3. Auditor Changes Wellgistics Health, Inc. engaged Suri & Co., Chartered Accountants as its auditor.
    “On November 17, 2025, the Audit Committee of the Board of Directors approved the re-engagement of Suri & Co., Chartered Accountants (“Suri”), as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.”
    November 17, 2025, 6:59 PM ET · SEC source · SEC 8-K Item 4.01/4.02
  4. Auditor Changes UHY LLP resigned as auditor of Wellgistics Health, Inc..
    “ormal notice that the Company’s independent auditors, UHY LLP (“UHY”), had made the decision to resign as the Company’s independent accountants effective November 11, 2025. UHY indicated that they have elected to resign in light of certain information identified in the resignation of the former Chief Executive Officer of the Company, which had not yet been investigated.”
    November 17, 2025, 6:59 PM ET · SEC source · SEC 8-K Item 4.01/4.02
  5. Governance Changes Wellgistics Health, Inc.: Certificate of Amendment to effect a 1-for-50 reverse stock split of common stock (effective 2025-05-26).
    “On May 20, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.”
    May 21, 2026, 6:51 AM ET · SEC source · SEC 8-K Item 5.03/5.05/5.06
  6. Gerald Commissiong was appointed as Interim Co-Chief Executive Officer at Wellgistics Health, Inc..
    “On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.”
    May 21, 2026, 6:51 AM ET · SEC source · SEC 8-K Item 5.02
  7. Michael L. Peterson was appointed as Director at Wellgistics Health, Inc..
    “the Board appointed Michael L. Peterson to fill the vacancy created as a result of Mr. Sayed’s departure.”
    April 11, 2025, 7:59 PM ET · SEC source · SEC 8-K Item 5.02
  8. Sajid Sayed resigned as Director at Wellgistics Health, Inc..
    “Sajid Sayed informed the Company’s board of directors of his intent to resign as a director of the Company, effective immediately.”
    April 11, 2025, 7:59 PM ET · SEC source · SEC 8-K Item 5.02
  9. Timothy Canning departed as Chief Executive Officer at Wellgistics Health, Inc..
    “Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.”
    March 6, 2025, 6:59 PM ET · SEC source · SEC 8-K Item 5.02
  10. Brian Norton was appointed as Chief Executive Officer at Wellgistics Health, Inc..
    “promoted Brian Norton to serve as the Company’s Chief Executive Officer effective as of February 28, 2025”
    March 6, 2025, 6:59 PM ET · SEC source · SEC 8-K Item 5.02
  11. Material Agreements Wellgistics Health, Inc. entered into Collaboration Agreement with Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC valued at $2,000,000 (effective 2026-04-13).
    “On April 13, 2026, Wellgistics Health, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with Kare Rx Hub, LLC (“Kare Hub”), Kare Pharmtech, LLC (“Kare Pharmtech”), and Healthstar Technologies, LLC (“Healthstar”), pursuant to which the parties agreed to collaborate through a newly formed limited liability company structure.”
    April 21, 2026, 7:59 PM ET · SEC source · SEC 8-K Item 1.01/1.02
  12. Material Agreements Wellgistics Health, Inc. entered into Forbearance Agreement with Marco Capital, Inc. valued at approximately $1.77 million (effective 2026-05-01).
    “On May 1, 2026, Wellgistics, LLC (“Wellgistics”), a wholly owned subsidiary of Wellgistics Health, Inc. (the “Company”), entered into an Acknowledgment of Indebtedness, Forbearance and Repayment Agreement (the “Forbearance Agreement”) with Marco Capital, Inc. (“MCI”).”
    May 7, 2026, 7:59 PM ET · SEC source · SEC 8-K Item 1.01/1.02

Recent 8-K filings for WGRX

Highest-materiality recent filing

Wellgistics Health enters binding term sheet for DelivMeds AI; announces 1-for-50 reverse stock split

May 21, 2026, 6:51 AM ET M&A materiality 0.85 neutral item 1.01item 2.03item 3.02item 3.03item 5.03item 5.02item 9.01

Read filing →

Executive changes

Appointed (interim)

Gerald Commissiong

Interim Co-Chief Executive Officer
WGRX · Wellgistics Health, Inc.
Effective
2026-05-20
Filed
May 21, 2026, 6:51 AM ET
On May 20, 2026, in connection with the Term Sheet described in Item 1.01 of this Current Report on Form 8-K, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Gerald Commissiong as Interim Co-Chief Executive Officer of the Company, effective immediately.
Departed

Vishnu Balu

Chief Financial Officer
WGRX · Wellgistics Health, Inc.
Effective
2025-04-22
Successor
Mark DiSiena
Filed
April 24, 2025, 7:59 PM ET
Mr. Balu’s decision to resign is not the result of any dispute or disagreement with the Company, the Company’s management or the Company’s Board of Directors on any matter relating to the Company’s operations, policies or practices.
Appointed

Mark DiSiena

Chief Financial Officer
WGRX · Wellgistics Health, Inc.
Effective
2025-04-22
Filed
April 24, 2025, 7:59 PM ET
On April 22, 2025, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Mark DiSiena as Chief Financial Officer of the Company, effective as of April 22, 2025
Departed

Sajid Sayed

Director
WGRX · Wellgistics Health, Inc.
Effective
2025-04-09
Successor
Michael L. Peterson
Filed
April 11, 2025, 7:59 PM ET
Sajid Sayed informed the Company’s board of directors of his intent to resign as a director of the Company, effective immediately.
Appointed

Michael L. Peterson

Director
WGRX · Wellgistics Health, Inc.
Effective
2025-04-10
Filed
April 11, 2025, 7:59 PM ET
the Board appointed Michael L. Peterson to fill the vacancy created as a result of Mr. Sayed’s departure.
Departed

Timothy Canning

Chief Executive Officer
WGRX · Wellgistics Health, Inc.
Effective
2025-02-28
Successor
Brian Norton
Filed
March 6, 2025, 6:59 PM ET
Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.
Appointed

Brian Norton

Chief Executive Officer
WGRX · Wellgistics Health, Inc.
Effective
2025-02-28
Filed
March 6, 2025, 6:59 PM ET
promoted Brian Norton to serve as the Company’s Chief Executive Officer effective as of February 28, 2025

Earnings & guidance

2026-Q1 EPS reported -$0.07 filing →

Materiality & sentiment trend

Max materiality 0.85 · Median 0.65 · Most common event other_material

15 positive 7 negative 28 neutral

source · WGRX on sec.gov